Physicians & Healthcare Providers Liability and prescribing boundaries: Doctors offering integrative, anti-aging, or sports medicine have faced legal and regulatory grey areas when prescribing Category 2 compounds
combination injectable therapy should be considered as initial therapy for patients with a blood glucose of 300 mg/dL or higher, patients with an A1C of 10% or higher, and patients who are markedly symptomatic
This increased risk may be related to the underlying disease process and not to any medication used for treatment Multiple endocrine neoplasia (MEN) is a rare genetic disorder that affects the endocrine system
Those numbers are significantly better than what semaglutide (Wegovy/Ozempic) achieves on its own
We will work with you to create a personalized Plan featuring a variety of science-backed therapies
Unlike the STEP-HFpEF trials, cardiovascular outcomes were included as a co-primary endpoint in the SUMMIT trial